Clinical trial
Tolerability and Efficacy of High Dose Escitalopram for the Treatment of…
NCT00305500 · Abarbanel Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00305500 |
|---|---|
| Title | Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD) |
| Official title | Phase III Open Study of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder in Adults |
| Lead sponsor | Abarbanel Mental Health Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obsessive-Compulsive Disorder |
| Intervention type | Drug |
| Interventions | escitalopram |
| Enrollment | 100 |
| Start date | Mar 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 22, 2006 |
| Last update posted | Jul 26, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: